What is Xencor Price-to-Operating-Cash-Flow?
As of today (2024-05-17), Xencor's share price is $22.46.
Xencor's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.99. Hence, Xencor's Price-to-Operating-Cash-Flow Ratio for today is 22.78.
The historical rank and industry rank for Xencor's Price-to-Operating-Cash-Flow or its related term are showing as below:
XNCR'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 7.46 Med: 22.44 Max: 317.24
Current: 21.59
During the past 13 years, Xencor's highest Price-to-Operating-Cash-Flow Ratio was 317.24. The lowest was 7.46. And the median was 22.44.
Xencor's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was $-0.90.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.99.
During the past 13 years, Xencor's highest 3-Year average Operating Cash Flow per Share Growth Rate was 50.50% per year. The lowest was -118.70% per year. And the median was -11.50% per year.
Xencor Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Xencor's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xencor Price-to-Operating-Cash-Flow Chart
|
Xencor Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
31.24 |
- |
- |
63.51 |
15.09 |
|
Xencor Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
- |
- |
15.09 |
22.44 |
Competitive Comparison of Xencor's Price-to-Operating-Cash-Flow
For the Biotechnology subindustry, Xencor's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xencor's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Xencor's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Xencor's Price-to-Operating-Cash-Flow falls into.
Xencor Price-to-Operating-Cash-Flow Calculation
Xencor's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 22.46 | / | 0.986 |
| = | 22.78 |
Xencor's Share Price of today is $22.46.
Xencor's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.99.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Xencor (Xencor) Business Description
Traded in Other Exchanges
Address
111 West Lemon Avenue, Monrovia, CA, USA, 91016
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045 and XmAb13676. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
Executives
| Bassil I Dahiyat |
director, officer: PRESIDENT & CEO |
C/O XENCOR, INC., 111 WEST LEMON AVENUE, MONROVIA CA 91016 |
| Barbara Klencke |
director |
C/O SIERRA ONCOLOGY, INC., 1820 GATEWAY DRIVE, SUITE 110, SAN MATEO CA 94404 |
| Allen Yang |
officer: SR. VICE PRESIDENT & CMO |
C/O XENCOR INC., 111 WEST LEMON AVENUE, MONROVIA CA 91016 |
| Celia Eckert |
officer: VP, GENERAL COUNSEL |
C/O XENCOR, INC., 111 WEST LEMON AVENUE, MONROVIA CA 91016 |
| John R Desjarlais |
officer: SR. VICE PRESIDENT & CSO |
C/O XENCOR, INC., 111 WEST LEMON AVENUE, MONROVIA CA 91016 |
| John J Kuch |
officer: SR. VICE PRESIDENT & CFO |
C/O XENCOR, INC., 111 WEST LEMON AVENUE, MONROVIA CA 91016 |
| Nancy Valente |
director |
C/O MYOVANT SCIENCES INC., 2000 SIERRA POINT PARKWAY, 9TH FLOOR, BRISBANE CA 94005 |
| Richard J Ranieri |
director |
3005 FIRST AVE, SEATTLE WA 98121 |
| Ellen Feigal |
director |
C/O XENCOR INC., 111 WEST LEMON AVENUE, MONROVIA CA 91016 |
| Yujiro S Hata |
director |
C/O XENCOR, INC., 111 WEST LEMON AVENUE, MONROVIA CA 91016 |
| Dagmar Rosa-bjorkeson |
director |
C/O BAXALTA INCORPORATED, 1200 LAKESIDE DRIVE, BANNOCKBURN IL 60015 |
| Alan Bruce Montgomery |
director |
1111 MAIN STREET, SUITE 660, VANCOUVER WA 98660 |
| Kevin Charles Gorman |
director |
12790 EL CAMINO REAL, SAN DIEGO CA 92130 |
| Kurt A Gustafson |
director |
11388 SORRENTO VALLEY ROAD, SAN DIEGO CA 92121 |
| Stafford John S Iii |
10 percent owner |
230 SOUTH LASALLE STREET 400, CHICAGO IL 60604 |
Xencor (Xencor) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XNCR has been successfully added to your